School of Medicine


Showing 941-950 of 4,922 Results

  • Beth Darnall

    Beth Darnall

    Professor of Anesthesiology, Perioperative and Pain Medicine (Adult Pain) and, by courtesy, of Psychiatry and Behavioral Sciences (General Psychiatry & Psychology (Adult))

    Current Research and Scholarly InterestsThe Stanford Pain Relief Innovations Lab is dedicated to better characterizing and treating pain with patient-centered solutions. We specialize in the conduct of large-scale acute and chronic pain clinical trials that aim to (1) expand and scale access to behavioral medicine via digital and brief treatments; (2) reduce opioid risks via reduction for some and improved opioid access for others; (3) equip healthcare providers with brief behavioral medicine interventions to optimize health outcomes.

  • Millie Das

    Millie Das

    Clinical Professor, Medicine - Oncology

    BioDr. Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and is an active member of the VA national Lung Cancer Working Group and Lung Cancer Precision Oncology Program. In 2023, she was elected President the Association of Northern California Oncologists (ANCO), where she displays her passion for patient advocacy and also for clinician education by helping to organize Bay Area focused continuing medical education programs. She is the VA site director for the Stanford fellowship program and leads the VA thoracic tumor board on a biweekly basis. She has a strong interest in clinical research, serving as a principal investigator for multiple clinical and translational studies at the Palo Alto VA, and also as a co-investigator on all of the lung cancer trials at Stanford. In her free time, she enjoys spending time with her family, traveling, and running.

  • Rhiju Das

    Rhiju Das

    Professor of Biochemistry

    Current Research and Scholarly InterestsOur lab seeks an agile and predictive understanding of how nucleic acids and proteins code for information processing in living systems. We develop new computational & chemical tools to enable the precise modeling, regulation, and design of RNA and RNA/protein machines.

  • Smita Das

    Smita Das

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioSmita Das, MD, PhD, MPH is Board Certified in Psychiatry, Addiction Psychiatry and Addiction Medicine. Dr. Das studied Chemistry and Statistics at Stanford, completed her Masters in Public Health at Dartmouth College, and then completed her MD/PhD in Community Health at the University of Illinois at Urbana Champaign. She completed psychiatry residency and was chief resident at Stanford followed by an addiction psychiatry fellowship at UCSF. She has over 2 decades of experience in research in healthcare quality and addiction. Dr. Das is a former chair of the APA Council on Addiction Psychiatry, a past president an APA District Branch and is on the Advisory Council for Workplace Mental Health at the APA. Dr. Das was Director of Addiction Treatment Services at the Palo Alto VA. Currently Dr. Das practices in addictions at Stanford School of Medicine where she is a Clinical Associate Professor and is also at a mental health start-up.

  • Debadutta (Dev) Dash, MD, MPH

    Debadutta (Dev) Dash, MD, MPH

    Clinical Assistant Professor, Emergency Medicine

    BioDr. Dash is an emergency medicine physician. He delivers care in the Stanford Health Care level 1 trauma center. He is an assistant professor in the Department of Emergency Medicine at Stanford University School of Medicine.

    He received fellowship training in clinical informatics at Stanford Health Care. He earned a Master of Public Health (MPH) degree from Harvard University.

    His research interests include computer vision and natural language processing. He is also interested in quality assurance and quality improvement in digital health initiatives.

    Other research projects of Dr. Dash include development of an image classification algorithm that helps predict hypoxic outcomes. He also worked on the development of a hardware and software system designed to provide real-time feedback about cardiac function at the patient’s bedside.

    Dr. Dash was vice president of the American Medical Informatics Association Clinical Fellows while completing his fellowship. He was also a post-doctoral research fellow at the Stanford University Center for Artificial Intelligence in Medicine & Imaging.

    He is a member of the American College of Emergency Physicians and American Academy of Emergency Medicine.

    He speaks English and Oriya fluently. He also speaks, reads, and writes Japanese and Spanish with intermediate competence.

    His interests outside of patient care include piano, computer programming, sustainable energy projects, and cooking multi-course East Asian meals.

  • Rajesh Dash, MD PhD;      Director of SSATHI & CardioClick

    Rajesh Dash, MD PhD; Director of SSATHI & CardioClick

    Associate Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsI have two research areas:
    1) Heart disease in South Asians - genetic, metabolic, & behavioral underpinnings of an aggressive phenotype.

    2) Imaging cell injury & recovery in the heart. Using Cardiac MRI to visualize signals of early injury and facilitating preventive medical therapy. Optimizing new imaging methods for viable cells to delineate live heart cells or transplanted stem cells.

  • Laura M.K. Dassama

    Laura M.K. Dassama

    Assistant Professor of Chemistry and of Microbiology and Immunology

    BioLaura Dassama is a chemical biologist who uses principles from chemistry and physics to understand complex biological phenomena, and to leverage that understanding for the modulation of biological processes. Her current research focuses on deciphering the molecular recognition mechanisms of multidrug transporters implicated in drug resistance, rational engineering and repurposing of natural products, and control of transcription factors relevant to sickle cell disease.